Gilead Sciences, Inc. (LON:0QYQ)
London · Delayed Price · Currency is GBP · Price in USD 127.73
+2.34 (1.87%)
At close: Nov 21, 2025
Gilead Sciences Market Cap
Gilead Sciences has a market cap or net worth of 118.64 billion as of November 25, 2025. Its market cap has increased by 33.77% in one year.
Market Cap
118.64B
Enterprise Value
129.60B
Revenue
21.64B
Ranking
n/a
PE Ratio
19.66
Stock Price
127.73
Market Cap Chart
Since January 22, 1992, Gilead Sciences's market cap has increased from 138.73M to 118.64B, an increase of 85,419.16%. That is a compound annual growth rate of 22.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 21, 2025 | 120.05B | 30.55% |
| Dec 31, 2024 | 91.95B | 16.03% |
| Dec 29, 2023 | 79.25B | -11.32% |
| Dec 30, 2022 | 89.37B | 32.86% |
| Dec 31, 2021 | 67.26B | 25.75% |
| Dec 31, 2020 | 53.49B | -13.83% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 214.31B |
| HSBC Holdings | 178.82B |
| Shell | 160.40B |
| Unilever | 114.15B |
| British American Tobacco p.l.c. | 91.95B |
| Rio Tinto Group | 89.89B |
| Rolls-Royce Holdings | 86.94B |
| GSK plc | 71.84B |